(DFEB) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F7713
DFEB: FLEX Options, Customized, Buffer, Equity
The FT Cboe Vest U.S. Equity Deep Buffer ETF - February (BATS:DFEB) is an exchange-traded fund that employs a defined outcome strategy, utilizing FLexible EXchange Options (FLEX Options) to track the performance of the SPDR S&P 500 ETF Trust. By investing in FLEX Options, the fund gains exposure to the underlying index while allowing for customization of key contract terms such as exercise prices, styles, and expiration dates. This approach enables the fund to manage risk and potentially mitigate losses during market downturns.
As a non-diversified fund, DFEBs investment strategy is centered around its FLEX Options, which are designed to provide a buffer against losses in the underlying ETF. The funds assets are invested substantially in these customized options, which trade on an exchange, offering a level of flexibility and control. With an AUM of $402.53 million, the fund has a considerable presence in the market.
Analyzing the technical data, we observe that the funds last price is $42.43, with a 20-day SMA of $41.73 and a 50-day SMA of $41.93, indicating a short-term bullish trend. The 200-day SMA at $42.05 suggests a longer-term neutral stance. The ATR of 0.60, equivalent to 1.42%, indicates moderate volatility. Given the current price action and the fact that the fund is trading near its 52-week high of $43.57, we can forecast that DFEB may continue to move upwards, potentially testing the resistance level around $43.57. However, a break below the 50-day SMA could signal a reversal, potentially targeting the $41.00 level.
Considering the fundamental data, the funds AUM of $402.53 million suggests a stable asset base. Combining this with the technical analysis, we can infer that DFEB is well-positioned to continue its upward trajectory, driven by the performance of the underlying S&P 500 index. As the market continues to evolve, the funds defined outcome strategy and use of FLEX Options are likely to remain key factors in its ability to navigate market fluctuations. A forecast based on the current technical and fundamental data suggests that DFEB may reach $44.50 in the next quarter, assuming the underlying index continues to perform positively.
Additional Sources for DFEB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
DFEB ETF Overview
Market Cap in USD | 420m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2020-02-21 |
DFEB ETF Ratings
Growth Rating | 70.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -3.64 |
Analysts | - |
Fair Price Momentum | 42.79 USD |
Fair Price DCF | - |
DFEB Dividends
Currently no dividends paidDFEB Growth Ratios
Growth Correlation 3m | 93.5% |
Growth Correlation 12m | 71% |
Growth Correlation 5y | 85.6% |
CAGR 5y | 8.29% |
CAGR/Max DD 5y | 0.83 |
Sharpe Ratio 12m | 1.15 |
Alpha | 1.71 |
Beta | 0.446 |
Volatility | 5.52% |
Current Volume | 17.4k |
Average Volume 20d | 22.2k |
As of July 01, 2025, the stock is trading at USD 44.64 with a total of 17,436 shares traded.
Over the past week, the price has changed by +1.53%, over one month by +2.62%, over three months by +5.92% and over the past year by +10.53%.
Yes. Based on ValueRay´s Analyses, FT Cboe Vest U.S. Equity (BATS:DFEB) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.55 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DFEB is around 42.79 USD . This means that DFEB is currently overvalued and has a potential downside of -4.14%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, DFEB FT Cboe Vest U.S. Equity will be worth about 47.8 in July 2026. The stock is currently trading at 44.64. This means that the stock has a potential upside of +7.15%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 47.8 | 7.1% |